ICAM1 and chronic myelogenous leukemia, BCR-ABL1 positive: ECs showed increased CD34, which is characteristic of CML-associated angiogenesis in human, and decreased VCAM-1 and β3-integrin, whereas MCs exhibited a markedly increased expression of ICAM-1 and CD44 (Fig 6B).